← Leaderboards
Jun Qu
State University Of New York At Buffalo
$2,101,366
Attributed
$4,218,769
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $982.6K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,218,769 · 4
By mechanism
U01$2,862,122 · 1
R21$1,029,513 · 2
U54$327,134 · 1
Top collaborators
- Robert M Straubinger4 shared
- Wei-Jun Qian3 shared
- Donald E Mager2 shared
- Alexis Cassandra Thompson2 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Ronald Berezney$2,863,723
- Robert M Straubinger$4,875,752
- Jonathan F Lovell$9,226,863
- Donald E Mager$1,901,673
- Elaine M Haase$156,000
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsSamplingClinical ResearchProteomicsTissuesPharmaceutical PreparationsUniversitiesValidationLaboratoriesReproducibilityMonitorCollaborationsPeptidesMedicineSmall MoleculeEvaluationMolecularData SetBioinformaticsProgramsLiquid Chromatography Mass SpectrometryProceduresPre-ClinicalPerformance
Grant awards (12)
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications$930,427
U01 · FY2025 · DK
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications$949,078
U01 · FY2024 · DK
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications$982,617
U01 · FY2023 · DK
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development$180,399
R21 · FY2020 · CA
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development$218,284
R21 · FY2019 · CA
Proteomics, Bioanalysis and Bioinformatics - E (Subaward)$64,484
U54 · FY2015 · HD · contact PI
Proteomics, Bioanalysis and Bioinformatics - E (Subaward)$61,704
U54 · FY2014 · HD · contact PI
Proteomics, Bioanalysis and Bioinformatics - E (Subaward)$62,494
U54 · FY2013 · HD · contact PI
Proteomics, Bioanalysis and Bioinformatics - E (Subaward)$61,761
U54 · FY2012 · HD · contact PI
Proteomics, Bioanalysis and Bioinformatics - E (Subaward)$76,691
U54 · FY2011 · HD · contact PI
Peripheral biomarkers of cocaine dependence and relapse$313,830
R21 · FY2010 · DA
Peripheral biomarkers of cocaine dependence and relapse$317,000
R21 · FY2009 · DA